American Thyroid Association
thyroid.org › home › patients portal › clinical thyroidology for the public › february 2024 › vol 17 issue 2 p.7-8
Long term outcomes of patients with Graves’ Disease
February 23, 2024 - Following the initial 2-year study, 82 patients (45%) had a relapse of their Graves’ disease. 20 years later only 11% of those that had relapsed were able to maintain normal thyroid function. The remaining 89% needed definitive treatment, either with radioactive iodine therapy or thyroid surgery. Some still used ATDs, while others had developed hypothyroidism. Among the 78 patients (43%) who achieved remission after the initial study, 62% had normal thyroid homone levels in the long term follow-up, with 14% having received definitive treatment.
Videos
01:36
What Is Graves’ Disease? | UCLA Endocrine Center - YouTube
EFL044 - Long-Term Medical Treatment of Graves Disease
27:28
Is Long-term Antithyroid Use the Best Treatment for Graves Disease?
16:10
19 Signs of HYPERTHYROIDISM (Graves Disease) You Can See: Doctor ...
01:05
Mayo Clinic Minute - Thyroid overdrive – understanding Graves' ...
05:41
Surgery for Graves’ Disease | UCLA Endocrine Center - YouTube
Oxford Academic
academic.oup.com › jcem › article › 109 › 3 › 827 › 7281824
Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
February 20, 2024 - Increasing scores (0-100) indicate more symptoms or effect. Two patients had received both RAI and thyroidectomy; they were allocated to the surgical group. Abbreviations: ATD, antithyroid drug; GD, Graves disease; HT, hypothyroidism; QoL, quality of life; RAI, radioiodine. Scores marked with a are significantly (adjusted P < .05) different from scores marked withb. Scrutiny of GD patients with the longest follow-up time ever reported confirms recent observations that only a third end up with normal thyroid function (7).
PubMed Central
pmc.ncbi.nlm.nih.gov › articles › PMC9946914
Long-term management of Graves disease: a narrative review - PMC
Sufficient RAI activity is recommended, with a mean dose of 10 to 15 mCi (370–555 MBq) to make the patient hypothyroid [3]. To improve its effectiveness, an ATD can be stopped 3 to 7 days before and after therapy. It may prevent a thyrotoxicosis aggravation from a long-term perspective, especially in elderly people and patients with underlying cardiovascular disease [20,21]. Although RAI is not associated with an increased risk of cancer, it can cause or worsen ophthalmopathy.
MedlinePlus
medlineplus.gov › home › health topics
Hyperthyroidism | Graves' Disease | Overactive Thyroid | MedlinePlus
These hormones affect nearly every organ in your body and control many of your body's most important functions. For example, they affect your breathing, heart rate, weight, digestion, and moods. If not treated, hyperthyroidism can cause serious problems with your heart, bones, muscles, menstrual cycle, and fertility. But there are treatments that can help. Hyperthyroidism has several causes. They include: Graves' disease, an autoimmune disorder in which your immune system attacks your thyroid and causes it to make too much hormone.
Mount Sinai
mountsinai.org › health-library › diseases-conditions › graves-disease
Graves disease Information | Mount Sinai - New York
May be used as a long-term treatment · Radioactive iodine is given by mouth. It then concentrates in the overactive thyroid tissue and causes damage. Surgery may be done to remove the thyroid. If you have had radioactive iodine treatment or surgery, you will need to take replacement thyroid hormones for the rest of your life. This is because these treatments destroy or remove the gland. TREATMENT OF THE EYES · Some of the eye problems related to Graves disease often improve after treatment with medicines (including selenium), radiation, or surgery.
Endocrinology and Metabolism
e-enm.org › journal › view.php
Treatment of Graves’ Disease: Faster Remission or Longer but Safe, That Is the Question
February 24, 2025 - Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves’ disease: a review of the literature. Clin Endocrinol (Oxf) 2021;95:3–12.ArticlePubMedPDF · 8. Kim YA, Cho SW, Choi HS, Moon S, Moon JH, Kim KW, et al. The second antithyroid drug treatment is effective in relapsed Graves’ disease patients: a median 11-year followup study.
Gdatf
gdatf.org › home › bulletins › psychosocial & emotional effects › what’s wrong with me
What’s Wrong With Me | Graves' Disease and Thyroid Foundation
August 18, 2021 - Most of these neurocognitive changes improve after successful treatment of Graves’ disease according to self-report and objective measures. Some cognitive deficits may not improve so easily in patients who have had untreated Graves’ for a long period of time.
Mamahealth
mamahealth.com › graves-disease › life-expectancy
How Long Can You Live With Graves' Disease? Expert Guide
Long-term studies show about one-third of patients achieved normal thyroid function with antithyroid medication, while 13% developed an underactive thyroid [7]. Plus, remission rates after antithyroid drug treatment range between 30-70%, meaning many people can effectively manage their condition [7]. Several key factors affect how long and how well you'll live with Graves' disease...
E-jyms
e-jyms.org › journal › view.php
Long-term management of Graves disease: a narrative review
November 4, 2022 - The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab 2014;99:3708–17.ArticlePubMed · 52. Törring O, Watt T, Sjölin G, Byström K, Abraham-Nordling M, Calissendorff J, et al. Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves’ hyperthyroidism: a long-term follow-up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Women's Health
womenshealth.gov › a-z-topics › graves-disease
Graves' disease | Office on Women's Health
October 24, 2025 - Graves' disease is an autoimmune disease that damages the thyroid gland. Graves' disease affects more women than men. It is the most common cause of hyperthyroidism (overactive thyroid gland). Symptoms of Graves' disease may include bulging eyes, weight loss, and a fast metabolism.
Healthgrades
resources.healthgrades.com › right-care › thyroid-disorders › graves-disease-prognosis-and-life-expectancy
Graves' Disease Life Expectancy: Complications and Outlook
February 21, 2025 - Generally, the outlook of Graves’ disease can be positive with early diagnosis and effective treatment. While Graves’ disease alone is not usually life threatening, it can cause health complications that may shorten life expectancy. Graves’ disease is one of the leading causes of hyperthyroidism, where your thyroid gland produces too much thyroid hormone. ... 2019 study Trusted Source PubMed Central Highly respected database from the National Institutes of Health Go to source notes that people with hyperthyroidism may have a higher risk of developing serious conditions.
Medscape
emedicine.medscape.com › tools & reference › endocrinology
Graves Disease: Background, Etiology, Pathophysiology
3 weeks ago - Clinical manifestations and complications of Graves disease include the following: Thyroid storm - This is an exaggerated state of thyrotoxicosis occurring in patients with inadequately treated thyrotoxicosis and a superimposed precipitating event (eg, surgery, infection, or trauma). [29] While the acute mortality rate in thyroid storm was historically near 100%, early recognition and aggressive therapy have reduced this figure. [30] Osteoporosis - Long-term thyroid hormone excess leads to osteoporosis.
ColumbiaDoctors
columbiadoctors.org › news › whats-best-way-treat-graves-disease
What’s the Best Way to Treat Graves’ Disease? | ColumbiaDoctors
March 12, 2024 - But it takes 12 to 18 months on medication to determine if Graves' disease will go into remission (when the thyroid gland is no longer overactive and antibodies are reduced to normal and/or undetectable levels). Recent data shows continuing medication can be safe and effective. In fact, emphasizes Lowe, lengthening the term to two years or more increases the possibility of ...
ScienceDirect
sciencedirect.com › science › article › pii › S2214623718301625
Graves’ disease and mental disorders - ScienceDirect
October 11, 2019 - Mental disorders merge highly with thyroid diseases. Because of its regulatory effects on serotonin and noradrenalin, T3 has been linked closely to depression and anxiety. It has known that in many cases, the mental symptoms persist even after normalization of thyroid function by treatment. Psychosocial factors including stress have been associated with mental symptoms even after thyroid function normalization in Graves’ disease and a combination of mental disorders have been related to the exacerbation of hyperthyroidism.